| Literature DB >> 31466340 |
Agnieszka Gęgotek1, Sinemyiz Atalay2, Pedro Domingues3, Elżbieta Skrzydlewska2.
Abstract
Cannabidiol (CBD), as the only phytocannabinoid that has no psychoactive effect, has both antioxidant and anti-inflammatory effects, and thus might be suggested as a cytoprotective compound against UV-induced metabolic changes in skin cells. Therefore, the aim of this study was to investigate the level of protective CBD activity by evaluating the proteomic profile of 2D and 3D cultured skin fibroblasts models following exposure to UVA and UVB radiation. The CBD cytoprotective effect against UV-induced damage in 2D and 3D cultured fibroblasts were different. The main alterations focus on the range of cell reaction and involved different proteins associated with various molecular functions. In the 2D cultured cells, following UV radiation, the major changes were associated with proteins involved in antioxidant response and inflammation, while, in the 3D cultured fibroblasts, CBD action against UV induced changes were mainly associated with the activation of signalling pathways. Therefore, the knowledge of the CBD action in a multilayer skin cells model allowed for the prediction of changes in cell-cell interactions and skin cell metabolism. Knowledge about the lower protective effect of CBD in 3D cultured fibroblasts should be taken into account during the design of UV light protection.Entities:
Keywords: 2D and 3D cell cultures; UV radiation; cannabidiol; proteomics; skin fibroblasts
Mesh:
Substances:
Year: 2019 PMID: 31466340 PMCID: PMC6770406 DOI: 10.3390/cells8090995
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Figure 1SDS-PAGE separation and staining with Coomassie Brilliant Blue R-250 of proteins from control skin fibroblasts and irradiated with UVA (20 J/cm2), UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) (A) or three-dimensional (3D) culture model (B). The grid indicates the borders of the protein migration zones.
Figure 2Principal component analysis (PCA) and top 10 loadings for component 1 (grouped according to their functions) of control skin fibroblasts and irradiated with UVA (20 J/cm2), UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) (A) or three-dimensional (3D) culture model (B).
Figure 3Volcano plots comparing the effect of cannabidiol (CBD, 4 µM) on control fibroblasts and UVA (20 J/cm2) or UVB (200 mJ/cm2) irradiated cells in two-dimensional (2D) or three-dimensional (3D) culture model. Significant features (in red) had p < 0.05.
Figure 4Heat map and clustering for the top 50 proteins (with smallest Q-value) from control skin fibroblasts and irradiated with UVA (20 J/cm2), UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) or three-dimensional (3D) culture model.
The list and biological/molecular functions of proteins that expression was significant changed in fibroblasts irradiated with UVA (20 J/cm2) and UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) or three-dimensional (3D) culture model.
| Changes | ID | Protein Name | Biological/Molecular Functions | Fold Change between Control and CBD Treated Cells | Fold Change between UVA Irradiated Cells and Irradiated Cells Treated with CBD | Fold Change between UVB Irradiated Cells and Irradiated Cells Treated with CBD | |||
|---|---|---|---|---|---|---|---|---|---|
| 2D | 3D | 2D | 3D | 2D | 3D | ||||
| INCREASE | Q02388 | collagen | structural | 3.7 | 2.1 | 4.1 | 2.3 | 4.0 | 2.7 |
| H7C4K3 | β1-integrin | structural | 6.1 | 4.5 | 4.0 | ||||
| P17301 | A2-integrin | structural | 4.9 | 6.1 | 5.4 | ||||
| P60709 | Actin | structural | 3.3 | 4.3 | 4.0 | ||||
| P12882 | Myosin-1 | structural | 3.6 | 3.9 | 3.5 | ||||
| Q14457 | Beclin-1 | structural | 6.2 | 6.1 | 6.7 | ||||
| Q20679 | 2-oxoglutarate 5-dioxygenase 2 | structural, collagen synthesis | 5.1 | ||||||
| Q9UL44 | Lysyl hydroxylase 1 | structural, collagen synthesis | 3.8 | 2.7 | |||||
| Q9Y6D3 | Lysyl hydroxylase 2 | structural, collagen synthesis | 4.3 | 3.1 | |||||
| Q86SQ4 | Adhesion G-protein coupled receptor G6 | structural, collagen binding | 4.2 | ||||||
| Q05397 | Focal adhesion kinase 1 (FAK1) | catalytic activity, kinase | 3.8 | 6.1 | 2.2 | 4.0 | 2.1 | 4.1 | |
| Q14289 | Focal adhesion kinase 2 (FAK2) | catalytic activity, kinase | 4.1 | 3.1 | 5.7 | 3.7 | 5.4 | ||
| Q15759 | p38 | catalytic activity, kinase | 6.4 | 8.1 | 6.1 | 9.0 | |||
| P31749 | Serine/threonine-protein kinase AKT1 | catalytic activity, kinase | 3.2 | 4.5 | 3.3 | 6.1 | 3.3 | 5.4 | |
| P31751 | Serine/threonine-protein kinase AKT2 | catalytic activity, kinase | 4.2 | 3.6 | 4.3 | 3.4 | 4.0 | ||
| Q9H8T0 | AKT-interacting protein (AktIP) | catalytic activity, kinase | 2.4 | 2.3 | |||||
| P27986 | Phosphoinositide 3-kinase (PI3K) | catalytic activity, kinase | 4.1 | 4.0 | 3.1 | 5.4 | 3.7 | 5.1 | |
| Q8IW41 | MAP kinase-activated protein kinase 5 (MAPKAPK5) | catalytic activity, kinase | 3.8 | 3.4 | |||||
| Q04206 | NF-kappa-B-repressing factor (NKRF) | intracellular signaling, anti-inflammatory factor | 4.3 | 3.9 | |||||
| P37231 | Peroxisome proliferator-activated receptor γ (PPARγ) | intracellular signaling, antioxidant response | 2.9 | 4.2 | 2.4 | 4.7 | |||
| Q03181 | Peroxisome proliferator-activated receptor δ (PPARδ) | intracellular signaling, antioxidant response | 3.4 | 5.1 | 3.7 | 5.2 | |||
| Q9UBK2 | Peroxisome proliferator-activated receptor gamma coactivator 1A (PPARGC1A) | intracellular signaling, antioxidant response | 2.6 | 4.9 | |||||
| D2KUA6 | NR1C3 (PPARγ subunit) | intracellular signaling, antioxidant response | 4.9 | 3.9 | |||||
| Q3C1U4 | PPARγ-DNA-binding domain-interacting protein 1β (PDIP1β) | intracellular signaling, antioxidant response | 3.3 | 3.1 | |||||
| P35669 | γ-Glutamate cysteine ligase A1 | catalytic activity, antioxidant response | 3.4 | 3.6 | |||||
| P22352 | Glutathione peroxidase 3 (GSH -Px3) | catalytic activity, antioxidant response | 6.2 | 3.7 | 2.0 | ||||
| P07203 | Glutathione peroxidase 1 (GSH -Px1) | catalytic activity, antioxidant response | 5.1 | 4.8 | 2.2 | ||||
| P08263 | Glutathione S-transferase A1 (GSTA1) | catalytic activity, antioxidant response | 3.2 | 2.1 | |||||
| P48637 | Glutathione synthetase | catalytic activity, antioxidant response | 3.2 | 3.8 | 4.4 | ||||
| V9HWJ1 | Glutathione synthetase, HEL-S-64p | catalytic activity, antioxidant response | 4.1 | 3.7 | |||||
| P48507 | Glutamate-cysteine ligase | catalytic activity, antioxidant response | 8.9 | ||||||
| Q8IU80 | Transmembrane protease serine 6 | catalytic activity, protease | 6.7 | ||||||
| P04083 | Annexin A1 | structural, transport | 4.2 | ||||||
| DECREASE | Q8NBJ5 | Procollagen galactosyltransferase 1 | catalytic activity, collagen metabolism | 0.3 | 0.4 | 0.2 | 0.2 | ||
| Q15582 | Transforming growth factor-beta-induced protein ig-h3 | structural, cell-collagen interactions | 0.2 | ||||||
| Q06828 | Fibromodulin | structural | 0.4 | ||||||
| P16671 | Platelet glycoprotein 4 | structural, cell-collagen interactions | 0.2 | 0.4 | 0.2 | 0.5 | 0.3 | 0.6 | |
| O14495 | Phospholipid phosphatase 3 | catalytic activity, phosphatase | 0.3 | 0.3 | 0.2 | ||||
| P45452 | Metalloproteinase-13 | catalytic activity, protein degradation | 0.3 | 0.4 | |||||
| P14780 | Metalloproteinase-9 | catalytic activity, protein degradation | 0.2 | 0.3 | 0.3 | 0.4 | 0.4 | 0.5 | |
| Q12884 | Prolyl endopeptidase FAP | catalytic activity, protein degradation | 0.3 | 0.4 | 0.4 | ||||
| P25774 | Cathepsin S | catalytic activity, protein degradation | 0.2 | 0.2 | |||||
| O61565 | I-kappa-B kinase (IKK) | catalytic activity, kinase, pro-inflammatory factor | 0.2 | 0.5 | 0.2 | 0.5 | |||
| O14920 | I-kappa-B kinase subunit B (IKKB) | catalytic activity, kinase, pro-inflammatory factor | 0.4 | 0.6 | 0.3 | ||||
| O15111 | I-kappa-B kinase subunit A (IKKA) | catalytic activity, kinase, pro-inflammatory factor | 0.2 | 0.4 | 0.3 | ||||
| O88619 | Nuclear factor NFκB (p65) | intracellular signaling, pro-inflammatory factor | 0.3 | 0.5 | 0.2 | 0.4 | |||
| P19838 | Nuclear factor NFκB (p105) | intracellular signaling, pro-inflammatory factor | 0.3 | 0.3 | 0.4 | ||||
| Q96P31 | Nuclear factor NFκB1 | intracellular signaling, pro-inflammatory factor | 0.2 | 0.2 | |||||
| Q04206 | NFκBID | intracellular signaling, pro-inflammatory factor | 0.3 | 0.3 | |||||
| P27487 | Dipeptidyl peptidase 4 | catalytic activity, protein degradation | 0.2 | 0.5 | 0.4 | 0.5 | 0.3 | 0.4 | |
| P48736 | Phosphatidylinositol 4,5-bisphosphate 3-kinase | catalytic activity, kinase | 0.2 | 0.8 | |||||
| Q15139 | Serine/threonine-protein kinase | catalytic activity, kinase | 0.3 | 0.6 | |||||
| P55085 | Proteinase-activated receptor 2 | catalytic activity, protein degradation | 0.4 | ||||||
| P35354 | Prostaglandin G/H synthase 2 | catalytic activity, lipid metabolism | 0.5 | ||||||
Figure 5The level of proteins modified by lipid peroxidation products (malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), acrolein) adducts formation in fibroblasts irradiated with UVA (20 J/cm2) and UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) or three-dimensional (3D) culture model. Mean values ± SD of tree independent experiments are presented. x—statistically significant differences between CBD treated and corresponding non-treated cells, Q < 0.05; a—statistically significant differences vs. control group, Q < 0.05; b—statistically significant differences vs. CBD treated group, Q < 0.05.
Figure 6The molecular functions of proteins modified by lipid peroxidation products (malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), acrolein) adducts formation in fibroblasts irradiated with UVA (20 J/cm2) and UVB (200 mJ/cm2) or/and treated with cannabidiol (CBD, 4 µM) in two-dimensional (2D) or three-dimensional (3D) culture model.